Back in May, Sarah Braner wrote that Japan was seeing a COVID-19 spike in the lead-up to the Tokyo Olympics, which are scheduled to start in late July. The situation has remained worrying since then.
True, cases have dropped significantly since the May outbreak—the nation is now seeing around 1,500 cases a day, compared to a peak of 6,500 on May 14. But many Japanese residents are concerned that the Olympic games could push numbers back up.
Despite a recent push towards vaccinations, Japan’s numbers remain low: just over 20% of the population has received at least one dose, as of June 24. On social media, Japanese residents have reported issues with getting their shots due to a voucher system implemented earlier this spring. A resident must receive a vaccine voucher from the government in order to get their shot; without that bureaucratic step, they may be turned away from a vaccine clinic, even if doses are available.
Meanwhile, rules around the Olympics have focused on protecting the athletes themselves. Over 80% of the athletes have been vaccinated and Japan will prioritize getting shots to Olympics staffers, journalists, and volunteers, according to the New York Times. Athletes will also be tested regularly.
The Olympics are not allowing international spectators, but officials announced this week that Japanese crowds will be permitted—up to 50% of a venue’s capacity. While masks will be required and other guidelines will be in place, the rules for attendees are not nearly so strict as those for athletes.
It only takes one unvaccinated person to set off a superspreading event. And with variants like Delta and Gamma spreading rapidly around the world, such events are more likely and more dangerous. In order to truly make the Olympics safe, Japan should ensure the coronavirus is locked out of Olympic events—not just for athletes, but for workers and spectators as well.
More international reporting
- Russia’s invasion of Ukraine has COVID-19 impactsWhen Russian troops began attacking Ukraine, the country was just recovering from its worst COVID-19 surge of the pandemic. To state the terrifying obvious: war makes it much harder to control a pandemic.
- We failed to vaccinate the world in 2021; will 2022 be more successful?In January, COVAX set a goal that many global health advocates considered modest: delivering 2.3 billion vaccine doses to low- and middle-income countries by the end of 2021. is saying it’ll deliver just 800 million vaccine doses by the end of 2021, according to the Washington Post, and only about 600 million had been delivered by early December.
- Omicron variant: What we know, what we don’t, and why not to panic (yet)On Thanksgiving, my Twitter feed was dominated not by food photos, but by news of a novel coronavirus variant identified in South Africa earlier this week. While the variant—now called Omicron, or B.1.1.529—likely didn’t originate in South Africa, data from the country’s comprehensive surveillance system provided enough evidence to suggest that this variant could be more contagious than Delta, as well as potentially more able to evade human immune systems.
- First COVID-19 antiviral pill gains authorizationThis week, an antiviral pill for COVID-19 was authorized in the U.K. The drug, made by American pharmaceutical company Merck, is the first COVID-19 treatment in pill form to gain approval by any regulatory agency.
- Unpacking Delta AY.4.2: Are we prepared for the next variant?Recently, a new offshoot of the Delta variant has been gaining ground in the U.K. It’s called AY.4.2, and it appears to be slightly more transmissible than Delta itself. While experts say this variant doesn’t differ enough from Delta to pose a serious concern, I think it’s worth exploring what we know about it so far—and what this means for the future of coronavirus mutation.